Comparison of Men's Prevention Apps to Research Efficacy

Summary

A randomized three arm control trial to examine the efficacy of two distinct apps (LYNX and MyChoices) developed for young men who have sex with men (YMSM) compared to standard of care (SOC) information about HIV testing and PrEP (Pre-Exposure Prophylaxis).

Conditions

• HIV/AIDS
• Sexually Transmitted Diseases
• Pre-exposure Prophylaxis
• Risk Reduction

Interventions

BEHAVIORAL

LYNX

Access to the LYNX mobile app which includes the Sex Pro score tool, sex diary, badges, PrEP information and video testimonials, HIV/STI testing reminders and geo-location features, and asynchronous chat feature.

BEHAVIORAL

MyChoices

Access to the MyChoices mobile app which includes the HIV test plan with reminders, STI information, PrEP resources, links to testing and PrEP sites, and geo-location features.

Sponsors & Collaborators

• Adolescent Trials Network for HIV/AIDS Interventions

  collaborator NETWORK

• Adolescent and Young Adult Research (AYAR), CORE Center

  collaborator UNKNOWN

• Children's Hospital of Philadelphia

  collaborator OTHER

• Baylor College of Medicine

  collaborator OTHER

• University of South Florida

  collaborator OTHER

• Emory University

  collaborator OTHER

• Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

  collaborator NIH

• Fenway Community Health

  collaborator OTHER

• San Francisco Department of Public Health

  collaborator OTHER_GOV

• University of North Carolina, Chapel Hill

  collaborator OTHER

• The Children's Hospital at Montefiore (CHAM)

  collaborator UNKNOWN

• National Institute on Drug Abuse (NIDA)

  collaborator NIH

• National Institute of Mental Health (NIMH)

  collaborator NIH

• Brown University

  collaborator OTHER

• RAIN, Inc.

  collaborator UNKNOWN

• Public Health Foundation Enterprises, Inc.

  lead OTHER

Principal Investigators

• Albert Y Liu, MD, MPH · San Francisco Department of Public Health

• Katie B Biello, PhD, MPH · Brown University

Study Design

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

15 Years

Max Age

29 Years

Sex

MALE

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2019-10-14

Primary Completion

2022-05-31

Completion

2022-05-31

Countries

• United States

Study Locations